The Israeli company Parasight, which during the St.Petersburg Economic Forum turned the 500th resident of the Skolkovo foundation, has developed a groundbreaking technology that allows advancing significantly in blood testing and diagnostics. Parasight technology outperforms all currently used alternatives, such as manual microscopy and others in cost, speed when it comes to diagnosis of blood deceases and detect blood parasites, as well as some hard to detect anomalies in blood. The equipment Parasight is using is suitable of the point-of-care setting and compatible with the conventional medical equipment, being used currently. The Parasight’s technology is based on computer-vision algorithms and some other break-through technologies.
As Parasight’s CEO Yossi Pollak wrote in the company’s executive summary, currently more than thirty percent of the global population lives in risk blood parasites areas. Malaria, is one of those dangerous deceases which takes away from 1-to 3 million lives annually. Chagas Decease and African sleeping sickness aren’t less dangerous. Meanwhile demand for on-site tests for blood deceases could be really huge, particularly in the third world countries. According to Parasight, only in India more than 100 million malaria tests were made.
At the St.Petersburg forum it was announced that Parasight will be one of those first residents, which will get an office in the first Skolkovo innovation center building, the Hypercube.